Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Depreciation & Amortization
Adaptive Biotechnologies Corp
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Depreciation & Amortization
-$14.2m
|
CAGR 3-Years
-103%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Depreciation & Amortization
-$2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Depreciation & Amortization
-$72.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-11%
|
|
Agilent Technologies Inc
NYSE:A
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Depreciation & Amortization
-$1.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Depreciation & Amortization?
Depreciation & Amortization
-14.2m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Depreciation & Amortization amounts to -14.2m USD.
What is Adaptive Biotechnologies Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-53%
Over the last year, the Depreciation & Amortization growth was 29%. The average annual Depreciation & Amortization growth rates for Adaptive Biotechnologies Corp have been -103% over the past three years , -53% over the past five years .